The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be diffi
A tale of two strands: Reverse-transcriptase polymerase chain reaction detection of hepatitis C virus replication
β Scribed by David V. Sangar; A. R. Carroll
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 270 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Among the three recently described GB viruses (GBV-A, GBV-B, and GBV-C), only GBV-C has been linked to cryptogenic hepatitis in man. Because of the limited utility of currently available research tests to determine antibody response t o GBV-C proteins, the prevalence of GBV-C RNA in human sera was s
The hepatitis C virus (HCV) is known to circulate in vivo as a quasispecies, a population of closely related, but genetically nonidentical virions. HCV reverse transcriptase (RT)-(nested) polymerase chain reaction (PCR) strategies are used to study quasispecies diversity at certain important viral g
Three PCR methods based on the GB virus-C/ hepatitis G virus (GBV-C/HGV) 5ΠUTR and NS3 genomic region were used for the detection of GBV-C/HGV RNA in serum of 62 patients with chronic hepatitis C virus (HCV) infection. Ten of 62 (16%) patients were found to have GBV-C/ HGV RNA, which was confirmed b
## Abstract The mean prevalence of antiβhepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired nonβA, nonβB (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
## Abstract Hepatitis C virus is one of the main causes of chronic hepatitis in developing countries. The current study was to evaluate the efficacy of the enzymeβlinked immunosorbent assay third generation (ELISAβ3) for detection of antibodies to hepatitis C virus (antiβHCV) in comparison with rev